Literature DB >> 3158201

Psychometric characteristics of the aberrant behavior checklist.

M G Aman, N N Singh, A W Stewart, C J Field.   

Abstract

Information was presented on the psychometric characteristics of the Aberrant Behavior Checklist. The internal consistency and test-retest reliability of the Checklist appeared to be very good. Interrater reliability tended to vary across raters and subscales and ranged from mediocre to good but was generally in the moderate range and acceptable for research purposes. Validity was assessed by comparing Checklist scores for residents presenting with attributes thought to reflect varying degrees of social adaptation. Validity was also evaluated by comparing Aberrant Behavior Checklist scores with ratings on adaptive behavior scales and with objective observations of behavior. In general, validity was established for most Aberrant Behavior Checklist subscales. Preliminary data from drug investigations suggested that the Checklist may provide a useful adjunct for the assessment of psychotropic drug effects.

Mesh:

Substances:

Year:  1985        PMID: 3158201

Source DB:  PubMed          Journal:  Am J Ment Defic        ISSN: 0002-9351


  116 in total

1.  Brief report: six months continuation treatment in naltrexone-responsive children with autism: an open-label case-control design.

Authors:  S H Willemsen-Swinkels; J K Buitelaar; I A van Berckelaer-Onnes; H van Engeland
Journal:  J Autism Dev Disord       Date:  1999-04

2.  Galantamine may be effective in treating autistic disorder.

Authors:  Helmut Niederhofer; W Staffen; A Mair
Journal:  BMJ       Date:  2002-12-14

3.  Factor validity and norms for the aberrant behavior checklist in a community sample of children with mental retardation.

Authors:  E C Marshburn; M G Aman
Journal:  J Autism Dev Disord       Date:  1992-09

4.  Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problems.

Authors:  Lawrence Scahill; Christopher J McDougle; Michael G Aman; Cynthia Johnson; Benjamin Handen; Karen Bearss; James Dziura; Eric Butter; Naomi G Swiezy; L Eugene Arnold; Kimberly A Stigler; Denis D Sukhodolsky; Luc Lecavalier; Stacie L Pozdol; Roumen Nikolov; Jill A Hollway; Patricia Korzekwa; Allison Gavaletz; Arlene E Kohn; Kathleen Koenig; Stacie Grinnon; James A Mulick; Sunkyung Yu; Benedetto Vitiello
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2011-12-23       Impact factor: 8.829

5.  Atomoxetine, Parent Training, and Their Combination in Children With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder.

Authors:  Benjamin L Handen; Michael G Aman; L Eugene Arnold; Susan L Hyman; Rameshwari V Tumuluru; Luc Lecavalier; Patricia Corbett-Dick; Xueliang Pan; Jill A Hollway; Kristin A Buchan-Page; Laura B Silverman; Nicole V Brown; Robert R Rice; Jessica Hellings; Daniel W Mruzek; Sarah McAuliffe-Bellin; Elizabeth A Hurt; Melissa M Ryan; Lynne Levato; Tristram Smith
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2015-09-03       Impact factor: 8.829

6.  The Aberrant Behavior Checklist with children and adolescents with dual diagnosis.

Authors:  J Rojahn; W J Helsel
Journal:  J Autism Dev Disord       Date:  1991-03

7.  Quality of life of adults with pervasive developmental disorders and intellectual disabilities.

Authors:  F Gerber; M A Baud; M Giroud; G Galli Carminati
Journal:  J Autism Dev Disord       Date:  2008-02-12

8.  The Behavior Problems Inventory: an instrument for the assessment of self-injury, stereotyped behavior, and aggression/destruction in individuals with developmental disabilities.

Authors:  J Rojahn; J L Matson; D Lott; A J Esbensen; Y Smalls
Journal:  J Autism Dev Disord       Date:  2001-12

9.  Analysis of short-term behavioral effects of dietary cholesterol supplementation in Smith-Lemli-Opitz syndrome.

Authors:  Elaine Tierney; Sandra K Conley; Halima Goodwin; Forbes D Porter
Journal:  Am J Med Genet A       Date:  2010-01       Impact factor: 2.802

10.  A double-blind, placebo-controlled trial of oral human immunoglobulin for gastrointestinal dysfunction in children with autistic disorder.

Authors:  Benjamin L Handen; Raun D Melmed; Robin L Hansen; Michael G Aman; David L Burnham; Jon B Bruss; Christopher J McDougle
Journal:  J Autism Dev Disord       Date:  2009-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.